Skip to main content
OpenTrials
Completed

NCT Number: NCT01154309

Group CBT for Depression and AOD Disorders

The investigators will adapt and test an existing treatment (group CBT for depression) for use in outpatient substance use treatment settings as delivered by trained substance use counselors. The investigators expect that treatment will lead to improved depression and substance use outcomes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Depression Behavior Behavioral Symptoms Chemically-Induced Disorders Mental Disorders Substance Use Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Behavioral Health Services, Inc

Gardena, California, 90249, United States

About this study

Aim 1. To adapt an existing group therapy (CBT for depression), creating a manualized treatment and accompanying implementation measures and tools for use with clients with persistent depressive symptoms and AOD disorders and to obtain preliminary assessments of the treatment from patient and provider perspectives.

Aim 2. To conduct a pilot test of the revised treatment in which we (a) demonstrate that when the therapy is implemented with fidelity, clinically significant reductions in depressive symptoms and AOD use occur; (b) estimate the likely effect size; and (c) investigate the underlying mechanisms of change, including both cognitive-behavioral and group processes and their relationship to depression and AOD treatment outcomes.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Enrolled in outpatient substance abuse program
  • BDI II score >13
  • Probable alcohol or substance use problem

Exclusion criteria

  • Cognitive impairment (Short Blessed > 10)
  • Probably bipolar or schizophrenic disorder

Treatment and study plan

Group CBT for Depression and AOD Disorders

Behavioral

18 sessions of 2-hour group CBT

Primary outcomes

  1. Reductions in depressive symptoms as measured by the BDI II

    Time frame: Post treatment

  2. Reductions in AOD use

    Time frame: Post treatment

Sponsors and collaborators

Lead sponsor

RAND

Other

Collaborators

  • Behavioral Health Services, Inc.

Registry information

Official study title

Group Cognitive Behavioral Therapy for Depression and Alcohol and Other Drug Disorders

Acronym: BRIGHT2

Important dates

Study start
2006
Primary completion
2009
Study completion
2009
First posted
Jun 30, 2010
Registry last updated
Nov 16, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.